const DATA = [
	{
		studyId: 'CT-001',
		title: 'Evaluation of Drug X for Treatment of Rheumatoid Arthritis',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 120,
		currentEnrollment: 120,
		startDate: '01/15/2023',
		plannedEndDate: '06/09/2025',
	},
	{
		studyId: 'CT-002',
		title: 'Novel Immunotherapy for Lung Cancer',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 200,
		currentEnrollment: 200,
		startDate: '02/20/2023',
		plannedEndDate: '08/05/2025',
	},
	{
		studyId: 'CT-003',
		title: 'New Vaccine for Emerging Virus',
		phase: 'Phase 1',
		status: 'Completed',
		enrollmentTarget: 300,
		currentEnrollment: 300,
		startDate: '03/10/2023',
		plannedEndDate: '11/01/2025',
	},
	{
		studyId: 'CT-004',
		title: 'Combination Therapy for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 180,
		currentEnrollment: 180,
		startDate: '02/28/2023',
		plannedEndDate: '08/05/2025',
	},
	{
		studyId: 'CT-005',
		title: 'Long-term Safety Study of Drug Y',
		phase: 'Phase 4',
		status: 'Completed',
		enrollmentTarget: 350,
		currentEnrollment: 350,
		startDate: '04/15/2023',
		plannedEndDate: '12/25/2025',
	},
	{
		studyId: 'CT-006',
		title: 'Biomarker Study in Early-Stage Lung Cancer',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 100,
		currentEnrollment: 100,
		startDate: '04/12/2023',
		plannedEndDate: '11/15/2025',
	},
	{
		studyId: 'CT-007',
		title: 'Topical Treatment for Skin Conditions',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 150,
		currentEnrollment: 150,
		startDate: '05/18/2023',
		plannedEndDate: '01/05/2026',
	},
	{
		studyId: 'CT-008',
		title: 'Advanced Gene Therapy for Rare Disorders',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 75,
		currentEnrollment: 75,
		startDate: '06/01/2023',
		plannedEndDate: '08/18/2026',
	},
	{
		studyId: 'CT-009',
		title: 'Monoclonal Antibody for Cancer',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 50,
		currentEnrollment: 50,
		startDate: '07/10/2023',
		plannedEndDate: '07/10/2025',
	},
	{
		studyId: 'CT-010',
		title: 'Oral Medication for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 250,
		currentEnrollment: 250,
		startDate: '08/05/2023',
		plannedEndDate: '02/02/2026',
	},
	{
		studyId: 'CT-011',
		title: 'Adjuvant Therapy for High-Risk Breast Cancer',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 350,
		currentEnrollment: 350,
		startDate: '09/15/2022',
		plannedEndDate: '08/09/2025',
	},
	{
		studyId: 'CT-012',
		title: 'Biologic Treatment for Severe Asthma',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 180,
		currentEnrollment: 180,
		startDate: '10/20/2023',
		plannedEndDate: '10/20/2025',
	},
	{
		studyId: 'CT-014',
		title: 'Microbiome Therapy for Digestive Disorders',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 200,
		currentEnrollment: 200,
		startDate: '01/25/2024',
		plannedEndDate: '06/30/2026',
	},
	{
		studyId: 'CT-015',
		title: 'Gene Therapy for Hemophilia A',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 100,
		currentEnrollment: 100,
		startDate: '03/05/2024',
		plannedEndDate: '03/05/2027',
	},
	{
		studyId: 'CT-105',
		title: 'Novel Antibody for Inflammatory Bowel Disease',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 180,
		currentEnrollment: 180,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-106',
		title: 'Targeted Therapy for FGFR-Altered Cholangiocarcinoma',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 90,
		currentEnrollment: 90,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-107',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 300,
		currentEnrollment: 300,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2027',
	},
	{
		studyId: 'CT-108',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 60,
		currentEnrollment: 60,
		startDate: '05/01/2024',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-109',
		title: 'Novel Approach for Gout',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 150,
		currentEnrollment: 150,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-110',
		title: 'Biologic for Moderate to Severe Asthma',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 400,
		currentEnrollment: 380,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2027',
	},
	{
		studyId: 'CT-111',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 120,
		currentEnrollment: 114,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-112',
		title: 'Targeted Therapy for ROS1-Positive Lung Cancer',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 80,
		currentEnrollment: 76,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-113',
		title: 'Novel Approach for Irritable Bowel Syndrome',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 350,
		currentEnrollment: 333,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2028',
	},
	{
		studyId: 'CT-114',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 400,
		currentEnrollment: 380,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2028',
	},
	{
		studyId: 'CT-115',
		title: 'Immunotherapy for Bladder Cancer',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 150,
		currentEnrollment: 143,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-116',
		title: 'Novel Approach for Endometriosis Pain',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 200,
		currentEnrollment: 190,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-117',
		title: 'Biologic Therapy for Psoriasis',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 300,
		currentEnrollment: 285,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-118',
		title: 'Targeted Therapy for MET-Amplified Gastric Cancer',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 100,
		currentEnrollment: 95,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2027',
	},
	{
		studyId: 'CT-119',
		title: 'Novel Treatment for Diabetic Retinopathy',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 250,
		currentEnrollment: 240,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2028',
	},
	{
		studyId: 'CT-120',
		title: 'Oral Therapy for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 350,
		currentEnrollment: 333,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2028',
	},
	{
		studyId: 'CT-121',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 120,
		currentEnrollment: 114,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-122',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 280,
		currentEnrollment: 266,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2028',
	},
	{
		studyId: 'CT-123',
		title: 'Novel Treatment for Osteoarthritis',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 150,
		currentEnrollment: 145,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-124',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 300,
		currentEnrollment: 285,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2026',
	},
	{
		studyId: 'CT-125',
		title: 'Targeted Therapy for NTRK-Fusion Cancers',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 80,
		currentEnrollment: 64,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2025',
	},
	{
		studyId: 'CT-126',
		title: 'Novel Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 200,
		currentEnrollment: 160,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2025',
	},
	{
		studyId: 'CT-127',
		title: 'Oral Treatment for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-128',
		title: 'Gene Therapy for Sickle Cell Disease',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 50,
		currentEnrollment: 40,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2026',
	},
	{
		studyId: 'CT-129',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2025',
	},
	{
		studyId: 'CT-130',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-131',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 180,
		currentEnrollment: 144,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2025',
	},
	{
		studyId: 'CT-132',
		title: 'Targeted Therapy for BRAF-Mutated Melanoma',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 250,
		currentEnrollment: 200,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2026',
	},
	{
		studyId: 'CT-133',
		title: 'Oral Treatment for Psoriasis',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-134',
		title: 'Innovative Approach for Multiple Sclerosis',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2025',
	},
	{
		studyId: 'CT-135',
		title: 'Combination Therapy for Advanced Ovarian Cancer',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 280,
		currentEnrollment: 224,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-136',
		title: 'Novel Treatment for Lupus',
		phase: 'Phase 2',
		status: 'Completed',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2026',
	},
	{
		studyId: 'CT-137',
		title: 'Biologic for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Completed',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2027',
	},
	{
		studyId: 'CT-019',
		title: 'Precision Medicine for Rare Genetic Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 40,
		currentEnrollment: 0,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2026',
	},
	{
		studyId: 'CT-233',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 0,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2026',
	},
	{
		studyId: 'CT-258',
		title: 'Gene Therapy for Rare Metabolic Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 0,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2028',
	},
	{
		studyId: 'CT-441',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 0,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-505',
		title: 'Gene Therapy for Hemophilia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 0,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2028',
	},
	{
		studyId: 'CT-056',
		title: 'Targeted Therapy for NTRK Fusion-Positive Solid Tumors',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 37,
		startDate: '03/10/2023',
		plannedEndDate: '06/30/2025',
	},
	{
		studyId: 'CT-057',
		title: 'Heart Failure Treatment with Preserved Ejection Fraction',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 500,
		currentEnrollment: 220,
		startDate: '04/15/2024',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-058',
		title: 'Oral Therapy for Relapsing Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 180,
		startDate: '05/22/2023',
		plannedEndDate: '11/22/2026',
	},
	{
		studyId: 'CT-059',
		title: 'Novel Approach for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 70,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-060',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 145,
		startDate: '08/10/2023',
		plannedEndDate: '11/10/2026',
	},
	{
		studyId: 'CT-143',
		title: 'Biologic for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 57,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-144',
		title: 'Novel Approach for Anxiety Disorders',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 82,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2026',
	},
	{
		studyId: 'CT-145',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 2,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-146',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 235,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2027',
	},
	{
		studyId: 'CT-147',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 5,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2026',
	},
	{
		studyId: 'CT-164',
		title: 'Targeted Therapy for RET-Fusion Lung Cancer',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 34,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-165',
		title: 'Novel Approach for Osteoarthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 89,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-166',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 29,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2028',
	},
	{
		studyId: 'CT-167',
		title: 'Gene Therapy for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 15,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2028',
	},
	{
		studyId: 'CT-168',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 11,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-191',
		title: 'Novel Approach for Bipolar Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 41,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2026',
	},
	{
		studyId: 'CT-192',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 210,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-193',
		title: 'Gene Therapy for Hemophilia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 19,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-194',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 91,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2026',
	},
	{
		studyId: 'CT-195',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 158,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-238',
		title: 'Innovative Approach for Multiple Sclerosis',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 77,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2026',
	},
	{
		studyId: 'CT-239',
		title: 'Combination Therapy for Advanced Ovarian Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 30,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-240',
		title: 'Novel Treatment for Lupus',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 116,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2026',
	},
	{
		studyId: 'CT-241',
		title: 'Biologic for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 269,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-242',
		title: 'Targeted Therapy for HER2-Positive Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 72,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2027',
	},
	{
		studyId: 'CT-337',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 114,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2026',
	},
	{
		studyId: 'CT-338',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 116,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2027',
	},
	{
		studyId: 'CT-339',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 40,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2026',
	},
	{
		studyId: 'CT-340',
		title: 'Targeted Therapy for HER2-Positive Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 134,
		startDate: '01/01/2024',
		plannedEndDate: '07/01/2027',
	},
	{
		studyId: 'CT-341',
		title: 'Oral Treatment for Psoriasis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 100,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2027',
	},
	{
		studyId: 'CT-342',
		title: 'Innovative Approach for Multiple Sclerosis',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 23,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-343',
		title: 'Combination Therapy for Advanced Ovarian Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 16,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2027',
	},
	{
		studyId: 'CT-344',
		title: 'Novel Treatment for Lupus',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 110,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2026',
	},
	{
		studyId: 'CT-345',
		title: 'Biologic for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 48,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2027',
	},
	{
		studyId: 'CT-346',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 88,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2027',
	},
	{
		studyId: 'CT-347',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 104,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-348',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 213,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2027',
	},
	{
		studyId: 'CT-349',
		title: 'Gene Therapy for Hemophilia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 9,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2027',
	},
	{
		studyId: 'CT-350',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 148,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-351',
		title: 'Biologic for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 21,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2027',
	},
	{
		studyId: 'CT-352',
		title: 'Novel Approach for Anxiety Disorders',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 107,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-353',
		title: 'Targeted Therapy for BRAF-Mutated Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 241,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2028',
	},
	{
		studyId: 'CT-354',
		title: 'Oral Treatment for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 273,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2028',
	},
	{
		studyId: 'CT-355',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 112,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-356',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 29,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2028',
	},
	{
		studyId: 'CT-357',
		title: 'Novel Treatment for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 171,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-358',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 197,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2028',
	},
	{
		studyId: 'CT-359',
		title: 'Targeted Therapy for PIK3CA-Mutated Breast Cancer',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 95,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-360',
		title: 'Novel Approach for Bipolar Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 8,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-361',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 325,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2028',
	},
	{
		studyId: 'CT-362',
		title: 'Gene Therapy for Rare Metabolic Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 23,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2028',
	},
	{
		studyId: 'CT-363',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-364',
		title: 'Biologic for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 206,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2026',
	},
	{
		studyId: 'CT-365',
		title: 'Novel Approach for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 137,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2025',
	},
	{
		studyId: 'CT-366',
		title: 'Targeted Therapy for HER2-Low Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 133,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-367',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 268,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-368',
		title: 'Innovative Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 183,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2025',
	},
	{
		studyId: 'CT-369',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 225,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-370',
		title: 'Novel Treatment for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 10,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2025',
	},
	{
		studyId: 'CT-371',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 93,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-372',
		title: 'Targeted Therapy for RET-Fusion Lung Cancer',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 14,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2025',
	},
	{
		studyId: 'CT-373',
		title: 'Novel Approach for Osteoarthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 32,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-374',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 41,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-375',
		title: 'Gene Therapy for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 53,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-376',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 149,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2026',
	},
	{
		studyId: 'CT-377',
		title: 'Biologic for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 194,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2027',
	},
	{
		studyId: 'CT-378',
		title: 'Novel Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 24,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2026',
	},
	{
		studyId: 'CT-379',
		title: 'Targeted Therapy for NTRK-Fusion Cancers',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 98,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-380',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 141,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-381',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 48,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2026',
	},
	{
		studyId: 'CT-382',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 97,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2027',
	},
	{
		studyId: 'CT-383',
		title: 'Novel Treatment for Type 1 Diabetes',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 141,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2026',
	},
	{
		studyId: 'CT-384',
		title: 'Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 219,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-385',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 99,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2026',
	},
	{
		studyId: 'CT-386',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 67,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2026',
	},
	{
		studyId: 'CT-387',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 182,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-388',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 29,
		startDate: '01/01/2024',
		plannedEndDate: '07/01/2027',
	},
	{
		studyId: 'CT-389',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 68,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-390',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 119,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2027',
	},
	{
		studyId: 'CT-391',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 129,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-392',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 193,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2027',
	},
	{
		studyId: 'CT-393',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 203,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2027',
	},
	{
		studyId: 'CT-394',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 6,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-395',
		title: 'Combination Therapy for Advanced Ovarian Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 183,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2027',
	},
	{
		studyId: 'CT-396',
		title: 'Novel Treatment for Lupus',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 8,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2026',
	},
	{
		studyId: 'CT-397',
		title: 'Biologic for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 244,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2027',
	},
	{
		studyId: 'CT-398',
		title: 'Targeted Therapy for HER2-Positive Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 298,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2027',
	},
	{
		studyId: 'CT-399',
		title: 'Novel Approach for Bipolar Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 164,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-400',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 230,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2028',
	},
	{
		studyId: 'CT-401',
		title: 'Gene Therapy for Hemophilia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 4,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2028',
	},
	{
		studyId: 'CT-402',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 1,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2027',
	},
	{
		studyId: 'CT-403',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 225,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2028',
	},
	{
		studyId: 'CT-404',
		title: 'Novel Approach for Anxiety Disorders',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 154,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-405',
		title: 'Targeted Therapy for BRAF-Mutated Melanoma',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 216,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-406',
		title: 'Oral Treatment for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 191,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2028',
	},
	{
		studyId: 'CT-407',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 11,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-408',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 289,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2028',
	},
	{
		studyId: 'CT-409',
		title: 'Novel Treatment for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 310,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2028',
	},
	{
		studyId: 'CT-410',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 226,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2028',
	},
	{
		studyId: 'CT-411',
		title: 'Targeted Therapy for PIK3CA-Mutated Breast Cancer',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 90,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-412',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 106,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2025',
	},
	{
		studyId: 'CT-413',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 144,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-414',
		title: 'Gene Therapy for Rare Metabolic Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 22,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-415',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 87,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2025',
	},
	{
		studyId: 'CT-416',
		title: 'Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 198,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2026',
	},
	{
		studyId: 'CT-417',
		title: 'Novel Approach for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 84,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2025',
	},
	{
		studyId: 'CT-418',
		title: 'Targeted Therapy for HER2-Low Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 87,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-419',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 368,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-420',
		title: 'Innovative Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 36,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2025',
	},
	{
		studyId: 'CT-421',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 323,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-422',
		title: 'Novel Treatment for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 81,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2025',
	},
	{
		studyId: 'CT-423',
		title: 'Biologic for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 115,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-424',
		title: 'Targeted Therapy for RET-Fusion Lung Cancer',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 77,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2026',
	},
	{
		studyId: 'CT-425',
		title: 'Novel Approach for Osteoarthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 121,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2027',
	},
	{
		studyId: 'CT-426',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 325,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2027',
	},
	{
		studyId: 'CT-427',
		title: 'Gene Therapy for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 4,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-428',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 117,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2026',
	},
	{
		studyId: 'CT-429',
		title: 'Biologic for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 170,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2027',
	},
	{
		studyId: 'CT-430',
		title: 'Novel Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 87,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2026',
	},
	{
		studyId: 'CT-431',
		title: 'Targeted Therapy for NTRK-Fusion Cancers',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 223,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-432',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 365,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-433',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 101,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2026',
	},
	{
		studyId: 'CT-434',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 0,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2027',
	},
	{
		studyId: 'CT-435',
		title: 'Novel Treatment for Type 1 Diabetes',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 131,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2026',
	},
	{
		studyId: 'CT-436',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 192,
		startDate: '01/01/2024',
		plannedEndDate: '07/01/2027',
	},
	{
		studyId: 'CT-437',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 23,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-438',
		title: 'Novel Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 27,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-439',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 109,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2027',
	},
	{
		studyId: 'CT-440',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 49,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2027',
	},
	{
		studyId: 'CT-442',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 165,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2027',
	},
	{
		studyId: 'CT-443',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 37,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-444',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 95,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2027',
	},
	{
		studyId: 'CT-445',
		title: 'Oral Treatment for Psoriasis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 221,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2027',
	},
	{
		studyId: 'CT-446',
		title: 'Innovative Approach for Multiple Sclerosis',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 32,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-447',
		title: 'Combination Therapy for Advanced Ovarian Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 43,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2027',
	},
	{
		studyId: 'CT-448',
		title: 'Novel Treatment for Lupus',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 88,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-449',
		title: 'Biologic for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 199,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2028',
	},
	{
		studyId: 'CT-450',
		title: 'Targeted Therapy for HER2-Positive Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 282,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2028',
	},
	{
		studyId: 'CT-451',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 154,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-452',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 217,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2028',
	},
	{
		studyId: 'CT-453',
		title: 'Gene Therapy for Hemophilia',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 6,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-454',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 52,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2027',
	},
	{
		studyId: 'CT-455',
		title: 'Biologic for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 131,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2028',
	},
	{
		studyId: 'CT-456',
		title: 'Novel Approach for Anxiety Disorders',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 153,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-457',
		title: 'Targeted Therapy for BRAF-Mutated Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 188,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2028',
	},
	{
		studyId: 'CT-458',
		title: 'Oral Treatment for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 248,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2028',
	},
	{
		studyId: 'CT-459',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 115,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-460',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 129,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2026',
	},
	{
		studyId: 'CT-461',
		title: 'Novel Treatment for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 65,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-462',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 131,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-463',
		title: 'Targeted Therapy for PIK3CA-Mutated Breast Cancer',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 10,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2025',
	},
	{
		studyId: 'CT-464',
		title: 'Novel Approach for Bipolar Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 1,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2025',
	},
	{
		studyId: 'CT-465',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 235,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-466',
		title: 'Gene Therapy for Rare Metabolic Disorder',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 10,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-467',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 67,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2025',
	},
	{
		studyId: 'CT-468',
		title: 'Biologic for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 264,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2026',
	},
	{
		studyId: 'CT-469',
		title: 'Novel Approach for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 95,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2025',
	},
	{
		studyId: 'CT-470',
		title: 'Targeted Therapy for HER2-Low Breast Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 204,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-471',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 332,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-472',
		title: 'Innovative Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 13,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2026',
	},
	{
		studyId: 'CT-473',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 65,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2027',
	},
	{
		studyId: 'CT-474',
		title: 'Novel Treatment for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Not yet recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 18,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2026',
	},
	{
		studyId: 'CT-475',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Not yet recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 4,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-016',
		title: "New Treatment for Alzheimer's Disease",
		phase: 'Phase 1',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 98,
		startDate: '04/12/2024',
		plannedEndDate: '07/12/2026',
	},
	{
		studyId: 'CT-017',
		title: 'Innovative Approach for Rheumatoid Arthritis',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 25,
		startDate: '05/01/2024',
		plannedEndDate: '04/15/2026',
	},
	{
		studyId: 'CT-018',
		title: 'Stem Cell Therapy for Degenerative Disc Disease',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 30,
		startDate: '01/30/2023',
		plannedEndDate: '10/15/2025',
	},
	{
		studyId: 'CT-020',
		title: 'Immunotherapy Combination for Advanced Renal Cell Carcinoma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 124,
		startDate: '10/05/2022',
		plannedEndDate: '10/05/2025',
	},
	{
		studyId: 'CT-021',
		title: 'New Oral Therapy for Hypertension',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 32,
		startDate: '09/22/2023',
		plannedEndDate: '11/15/2025',
	},
	{
		studyId: 'CT-022',
		title: 'Biologics for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 72,
		startDate: '11/10/2023',
		plannedEndDate: '05/10/2026',
	},
	{
		studyId: 'CT-023',
		title: 'Digital Therapeutic for Diabetes Management',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 500,
		currentEnrollment: 68,
		startDate: '09/01/2022',
		plannedEndDate: '09/01/2025',
	},
	{
		studyId: 'CT-024',
		title: 'Investigational Therapy for Metastatic Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 41,
		startDate: '01/10/2024',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-025',
		title: 'Innovative Antipsychotic for Schizophrenia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 99,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2025',
	},
	{
		studyId: 'CT-026',
		title: 'Nasal Spray for Allergic Rhinitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 73,
		startDate: '07/20/2023',
		plannedEndDate: '10/20/2026',
	},
	{
		studyId: 'CT-027',
		title: 'Inhaled Formulation for Cystic Fibrosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 221,
		startDate: '11/22/2022',
		plannedEndDate: '09/30/2025',
	},
	{
		studyId: 'CT-028',
		title: 'Targeted Therapy for KRAS-Mutated Colorectal Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 25,
		startDate: '02/15/2023',
		plannedEndDate: '06/05/2025',
	},
	{
		studyId: 'CT-029',
		title: 'Antifungal for Resistant Infections',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 129,
		startDate: '03/20/2024',
		plannedEndDate: '02/22/2026',
	},
	{
		studyId: 'CT-030',
		title: 'Hormone Therapy for Endometriosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 96,
		startDate: '04/08/2024',
		plannedEndDate: '12/12/2026',
	},
	{
		studyId: 'CT-031',
		title: 'CAR-T Cell Therapy for Refractory Lymphoma',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 75,
		currentEnrollment: 16,
		startDate: '05/12/2024',
		plannedEndDate: '05/12/2027',
	},
	{
		studyId: 'CT-032',
		title: 'Novel Anti-Inflammatory for Psoriatic Arthritis',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 78,
		startDate: '06/15/2024',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-033',
		title: "Neuroprotective Agent for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 42,
		startDate: '07/01/2024',
		plannedEndDate: '07/01/2027',
	},
	{
		studyId: 'CT-034',
		title: 'Oral GLP-1 Agonist for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 450,
		currentEnrollment: 83,
		startDate: '08/05/2024',
		plannedEndDate: '09/01/2027',
	},
	{
		studyId: 'CT-035',
		title: 'Gene Therapy for Hemophilia B',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 6,
		startDate: '09/20/2022',
		plannedEndDate: '12/20/2025',
	},
	{
		studyId: 'CT-036',
		title: 'Oral Agent for Non-Alcoholic Steatohepatitis',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 69,
		startDate: '10/15/2023',
		plannedEndDate: '01/10/2026',
	},
	{
		studyId: 'CT-037',
		title: 'Antibody-Drug Conjugate for HER2-Low Breast Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 44,
		startDate: '11/22/2023',
		plannedEndDate: '03/30/2026',
	},
	{
		studyId: 'CT-038',
		title: 'Oral Therapy for Moderate to Severe Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 276,
		startDate: '12/01/2023',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-039',
		title: 'Novel Antiviral for Respiratory Syncytial Virus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 47,
		startDate: '01/05/2024',
		plannedEndDate: '08/05/2026',
	},
	{
		studyId: 'CT-040',
		title: 'Targeted Therapy for IDH-Mutated Glioma',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 31,
		startDate: '03/20/2023',
		plannedEndDate: '09/10/2025',
	},
	{
		studyId: 'CT-041',
		title: 'Novel Treatment for Osteoarthritis Pain',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 298,
		startDate: '11/15/2022',
		plannedEndDate: '05/30/2025',
	},
	{
		studyId: 'CT-042',
		title: 'Advanced Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 201,
		startDate: '02/15/2024',
		plannedEndDate: '09/15/2027',
	},
	{
		studyId: 'CT-043',
		title: 'Novel Approach for Hypertension',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 82,
		startDate: '03/01/2024',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-044',
		title: 'Immunotherapy for Early-Stage Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 600,
		currentEnrollment: 308,
		startDate: '08/22/2022',
		plannedEndDate: '08/22/2026',
	},
	{
		studyId: 'CT-045',
		title: 'Oncolytic Virus for Metastatic Melanoma',
		phase: 'Phase 1',
		status: 'Recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 34,
		startDate: '04/10/2024',
		plannedEndDate: '04/10/2026',
	},
	{
		studyId: 'CT-046',
		title: 'Pegylated Interferon for Hepatitis C',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 197,
		startDate: '05/15/2024',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-047',
		title: 'Novel Treatment for Sickle Cell Anemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 89,
		startDate: '06/20/2024',
		plannedEndDate: '01/20/2026',
	},
	{
		studyId: 'CT-048',
		title: 'Monoclonal Antibody for Severe Eosinophilic Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 171,
		startDate: '07/10/2023',
		plannedEndDate: '12/10/2026',
	},
	{
		studyId: 'CT-049',
		title: 'Novel Approach for Opioid Use Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 25,
		startDate: '08/05/2023',
		plannedEndDate: '06/05/2025',
	},
	{
		studyId: 'CT-050',
		title: 'Combination Immunotherapy for Advanced Melanoma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 450,
		currentEnrollment: 123,
		startDate: '09/08/2022',
		plannedEndDate: '05/05/2026',
	},
	{
		studyId: 'CT-051',
		title: "Novel Treatment for Huntington's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 20,
		startDate: '10/15/2023',
		plannedEndDate: '04/20/2027',
	},
	{
		studyId: 'CT-052',
		title: 'Oral Therapy for Pulmonary Arterial Hypertension',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 139,
		startDate: '11/22/2023',
		plannedEndDate: '10/22/2026',
	},
	{
		studyId: 'CT-053',
		title: 'Novel Approach for Acute Myeloid Leukemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 70,
		currentEnrollment: 37,
		startDate: '01/25/2023',
		plannedEndDate: '12/15/2025',
	},
	{
		studyId: 'CT-054',
		title: "Biologic Therapy for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 210,
		startDate: '03/10/2024',
		plannedEndDate: '08/10/2027',
	},
	{
		studyId: 'CT-055',
		title: 'Novel Treatment for Diabetic Kidney Disease',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 67,
		startDate: '02/01/2024',
		plannedEndDate: '02/01/2026',
	},
	{
		studyId: 'CT-061',
		title: 'Novel Approach for Major Depressive Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 87,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2026',
	},
	{
		studyId: 'CT-062',
		title: 'Targeted Therapy for BRAF-Mutated Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 118,
		startDate: '10/05/2023',
		plannedEndDate: '07/05/2026',
	},
	{
		studyId: 'CT-063',
		title: 'Innovative Treatment for Amyotrophic Lateral Sclerosis',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 97,
		startDate: '11/08/2023',
		plannedEndDate: '08/08/2026',
	},
	{
		studyId: 'CT-064',
		title: 'Biologic Therapy for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 9,
		startDate: '01/10/2024',
		plannedEndDate: '01/10/2027',
	},
	{
		studyId: 'CT-065',
		title: 'Chronic Obstructive Pulmonary Disease New Treatment',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 398,
		startDate: '02/15/2024',
		plannedEndDate: '09/15/2027',
	},
	{
		studyId: 'CT-066',
		title: 'Therapy for PIK3CA-Mutated Cancers',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 37,
		startDate: '03/01/2023',
		plannedEndDate: '11/15/2025',
	},
	{
		studyId: 'CT-067',
		title: 'Innovative Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 6,
		startDate: '04/20/2024',
		plannedEndDate: '10/20/2026',
	},
	{
		studyId: 'CT-068',
		title: 'Oral Therapy for Chronic Hepatitis B',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 30,
		startDate: '11/12/2022',
		plannedEndDate: '05/15/2026',
	},
	{
		studyId: 'CT-069',
		title: 'Novel Approach for Postpartum Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 27,
		startDate: '02/15/2023',
		plannedEndDate: '12/15/2025',
	},
	{
		studyId: 'CT-070',
		title: 'Combination Therapy for Triple-Negative Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 248,
		startDate: '05/10/2024',
		plannedEndDate: '03/10/2027',
	},
	{
		studyId: 'CT-071',
		title: 'Experimental Treatment for Spinal Muscular Atrophy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 144,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2027',
	},
	{
		studyId: 'CT-072',
		title: 'Hidradenitis Suppurativa Biologic Therapy',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 237,
		startDate: '07/15/2023',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-073',
		title: 'Narcolepsy New Medication',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 35,
		startDate: '07/01/2024',
		plannedEndDate: '07/01/2026',
	},
	{
		studyId: 'CT-074',
		title: 'Therapy for RET-Altered Thyroid Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 18,
		startDate: '08/20/2023',
		plannedEndDate: '04/20/2026',
	},
	{
		studyId: 'CT-075',
		title: 'Treatment for Primary Biliary Cholangitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 21,
		startDate: '09/15/2023',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-076',
		title: 'Obesity New Oral Therapy',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 18,
		startDate: '10/01/2023',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-077',
		title: 'Novel Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 116,
		startDate: '11/12/2023',
		plannedEndDate: '08/12/2026',
	},
	{
		studyId: 'CT-078',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 149,
		startDate: '10/22/2024',
		plannedEndDate: '04/22/2027',
	},
	{
		studyId: 'CT-079',
		title: 'Treatment for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 77,
		startDate: '03/05/2024',
		plannedEndDate: '10/05/2026',
	},
	{
		studyId: 'CT-080',
		title: 'Biologic Therapy for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 152,
		startDate: '05/08/2024',
		plannedEndDate: '05/08/2027',
	},
	{
		studyId: 'CT-081',
		title: 'Innovative Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 156,
		startDate: '08/15/2023',
		plannedEndDate: '01/15/2026',
	},
	{
		studyId: 'CT-082',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 177,
		startDate: '09/20/2023',
		plannedEndDate: '05/20/2027',
	},
	{
		studyId: 'CT-083',
		title: 'Chronic Kidney Disease New Treatment',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 143,
		startDate: '04/05/2024',
		plannedEndDate: '04/05/2027',
	},
	{
		studyId: 'CT-084',
		title: 'Novel Oral Therapy for Systemic Sclerosis',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 20,
		startDate: '01/15/2024',
		plannedEndDate: '06/15/2026',
	},
	{
		studyId: 'CT-085',
		title: 'Innovative Approach for Bipolar Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 18,
		startDate: '02/01/2024',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-086',
		title: 'Combination Therapy for Metastatic Pancreatic Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 46,
		startDate: '08/15/2023',
		plannedEndDate: '10/15/2025',
	},
	{
		studyId: 'CT-087',
		title: 'Treatment for Hemophilia A',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 25,
		startDate: '07/10/2024',
		plannedEndDate: '06/10/2027',
	},
	{
		studyId: 'CT-088',
		title: 'Biologic Therapy for Non-Radiographic Axial Spondyloarthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 220,
		currentEnrollment: 82,
		startDate: '08/22/2023',
		plannedEndDate: '12/22/2026',
	},
	{
		studyId: 'CT-089',
		title: 'Novel Approach for Schizophrenia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 84,
		startDate: '09/18/2023',
		plannedEndDate: '03/18/2026',
	},
	{
		studyId: 'CT-090',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 13,
		startDate: '07/15/2022',
		plannedEndDate: '01/05/2026',
	},
	{
		studyId: 'CT-091',
		title: 'New Treatment for Gastroparesis',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 57,
		startDate: '09/01/2023',
		plannedEndDate: '05/01/2025',
	},
	{
		studyId: 'CT-092',
		title: 'Oral Therapy for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 171,
		startDate: '11/05/2022',
		plannedEndDate: '06/05/2026',
	},
	{
		studyId: 'CT-093',
		title: 'Innovative Approach for Chronic Migraine',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 45,
		startDate: '05/20/2023',
		plannedEndDate: '11/20/2026',
	},
	{
		studyId: 'CT-094',
		title: 'Combination Therapy for Metastatic Renal Cell Carcinoma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 174,
		startDate: '06/08/2024',
		plannedEndDate: '04/08/2027',
	},
	{
		studyId: 'CT-095',
		title: 'Novel Therapy for Myelofibrosis',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 3,
		startDate: '07/18/2023',
		plannedEndDate: '10/18/2025',
	},
	{
		studyId: 'CT-096',
		title: 'Biologic Therapy for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 320,
		currentEnrollment: 187,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2028',
	},
	{
		studyId: 'CT-097',
		title: 'Innovative Treatment for Acute Myocardial Infarction',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 53,
		startDate: '09/10/2023',
		plannedEndDate: '03/10/2027',
	},
	{
		studyId: 'CT-098',
		title: 'Targeted Therapy for HER2-Positive Gastric Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 217,
		startDate: '10/08/2022',
		plannedEndDate: '04/20/2026',
	},
	{
		studyId: 'CT-099',
		title: 'New Treatment for Osteoporosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 7,
		startDate: '11/22/2023',
		plannedEndDate: '05/22/2027',
	},
	{
		studyId: 'CT-100',
		title: 'Oral Therapy for Moderate to Severe Plaque Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 89,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-101',
		title: 'Oral therapy for Migraine Relief',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 102,
		startDate: '01/01/2024',
		plannedEndDate: '07/15/2027',
	},
	{
		studyId: 'CT-102',
		title: 'Immunotherapy for Relapsed Leukemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 48,
		startDate: '01/15/2024',
		plannedEndDate: '03/30/2026',
	},
	{
		studyId: 'CT-103',
		title: 'Combination Therapy for Eczema',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 87,
		startDate: '02/05/2024',
		plannedEndDate: '08/05/2026',
	},
	{
		studyId: 'CT-104',
		title: 'Antiviral for Hepatitis C',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 76,
		startDate: '03/01/2024',
		plannedEndDate: '09/30/2026',
	},
	{
		studyId: 'CT-138',
		title: 'Targeted Therapy for HER2-Positive Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 15,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2027',
	},
	{
		studyId: 'CT-139',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 171,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2026',
	},
	{
		studyId: 'CT-140',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 256,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-141',
		title: 'Gene Therapy for Hemophilia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 59,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2027',
	},
	{
		studyId: 'CT-142',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 76,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2026',
	},
	{
		studyId: 'CT-148',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 228,
		startDate: '01/01/2024',
		plannedEndDate: '07/01/2027',
	},
	{
		studyId: 'CT-149',
		title: 'Novel Treatment for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 246,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2027',
	},
	{
		studyId: 'CT-150',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 197,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2027',
	},
	{
		studyId: 'CT-151',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 43,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-152',
		title: 'Novel Approach for Bipolar Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 150,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2026',
	},
	{
		studyId: 'CT-153',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 344,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2027',
	},
	{
		studyId: 'CT-154',
		title: 'Gene Therapy for Rare Metabolic Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 11,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2027',
	},
	{
		studyId: 'CT-155',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 19,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-156',
		title: 'Biologic for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 140,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2027',
	},
	{
		studyId: 'CT-157',
		title: 'Novel Approach for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 58,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-158',
		title: 'Targeted Therapy for PIK3CA-Mutated Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 261,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2027',
	},
	{
		studyId: 'CT-159',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 358,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2027',
	},
	{
		studyId: 'CT-160',
		title: 'Innovative Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 162,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-161',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 178,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2028',
	},
	{
		studyId: 'CT-162',
		title: 'Novel Treatment for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 2,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2027',
	},
	{
		studyId: 'CT-163',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 105,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2028',
	},
	{
		studyId: 'CT-169',
		title: 'Biologic for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 26,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2028',
	},
	{
		studyId: 'CT-170',
		title: 'Novel Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 27,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2027',
	},
	{
		studyId: 'CT-171',
		title: 'Targeted Therapy for BRAF-Mutated Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 234,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2028',
	},
	{
		studyId: 'CT-172',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 21,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2026',
	},
	{
		studyId: 'CT-173',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 72,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2025',
	},
	{
		studyId: 'CT-174',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 42,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-175',
		title: 'Novel Treatment for Type 1 Diabetes',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 97,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2025',
	},
	{
		studyId: 'CT-176',
		title: 'Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 256,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2026',
	},
	{
		studyId: 'CT-177',
		title: 'Targeted Therapy for HER2-Low Breast Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 33,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2025',
	},
	{
		studyId: 'CT-178',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 122,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2025',
	},
	{
		studyId: 'CT-179',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 193,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-180',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 23,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2026',
	},
	{
		studyId: 'CT-181',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 5,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2025',
	},
	{
		studyId: 'CT-182',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 123,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-183',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 104,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2025',
	},
	{
		studyId: 'CT-184',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 17,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-185',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 190,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2027',
	},
	{
		studyId: 'CT-186',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 127,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2026',
	},
	{
		studyId: 'CT-187',
		title: 'Combination Therapy for Advanced Ovarian Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 237,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-188',
		title: 'Novel Treatment for Lupus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 66,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2026',
	},
	{
		studyId: 'CT-189',
		title: 'Biologic for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 220,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2027',
	},
	{
		studyId: 'CT-190',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 62,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2027',
	},
	{
		studyId: 'CT-196',
		title: 'Novel Approach for Anxiety Disorders',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 48,
		startDate: '01/01/2025',
		plannedEndDate: '07/15/2025',
	},
	{
		studyId: 'CT-197',
		title: 'Targeted Therapy for BRAF-Mutated Melanoma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 38,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2027',
	},
	{
		studyId: 'CT-198',
		title: 'Oral Treatment for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 173,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2027',
	},
	{
		studyId: 'CT-199',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 12,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-200',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 90,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2027',
	},
	{
		studyId: 'CT-201',
		title: 'Novel Treatment for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 120,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2027',
	},
	{
		studyId: 'CT-202',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 75,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2027',
	},
	{
		studyId: 'CT-203',
		title: 'Targeted Therapy for HER2-Positive Breast Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 30,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-204',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 54,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2026',
	},
	{
		studyId: 'CT-205',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 105,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2027',
	},
	{
		studyId: 'CT-206',
		title: 'Gene Therapy for Rare Metabolic Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 15,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2027',
	},
	{
		studyId: 'CT-207',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 36,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-208',
		title: 'Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 90,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2028',
	},
	{
		studyId: 'CT-209',
		title: 'Novel Approach for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 45,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2027',
	},
	{
		studyId: 'CT-210',
		title: 'Targeted Therapy for PIK3CA-Mutated Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 84,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2028',
	},
	{
		studyId: 'CT-211',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 120,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2028',
	},
	{
		studyId: 'CT-212',
		title: 'Innovative Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 60,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-213',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 105,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-214',
		title: 'Novel Treatment for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 36,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2027',
	},
	{
		studyId: 'CT-215',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 90,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2028',
	},
	{
		studyId: 'CT-216',
		title: 'Targeted Therapy for RET-Fusion Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 24,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-217',
		title: 'Novel Approach for Osteoarthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 75,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2028',
	},
	{
		studyId: 'CT-218',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 105,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2028',
	},
	{
		studyId: 'CT-219',
		title: 'Gene Therapy for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 18,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2028',
	},
	{
		studyId: 'CT-220',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 45,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2025',
	},
	{
		studyId: 'CT-221',
		title: 'Biologic for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 84,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-222',
		title: 'Novel Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 54,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2025',
	},
	{
		studyId: 'CT-223',
		title: 'Targeted Therapy for NTRK-Fusion Cancers',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 75,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-224',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 120,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2026',
	},
	{
		studyId: 'CT-225',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 36,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2025',
	},
	{
		studyId: 'CT-226',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 90,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-227',
		title: 'Novel Treatment for Type 1 Diabetes',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 45,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2025',
	},
	{
		studyId: 'CT-228',
		title: 'Biologic for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 105,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2026',
	},
	{
		studyId: 'CT-229',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 30,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2025',
	},
	{
		studyId: 'CT-230',
		title: 'Novel Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 60,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2025',
	},
	{
		studyId: 'CT-231',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 120,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-232',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 15,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-234',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 90,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2027',
	},
	{
		studyId: 'CT-235',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 54,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2026',
	},
	{
		studyId: 'CT-236',
		title: 'Targeted Therapy for BRAF-Mutated Melanoma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 75,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-237',
		title: 'Oral Treatment for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 120,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2027',
	},
	{
		studyId: 'CT-243',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 60,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2026',
	},
	{
		studyId: 'CT-244',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 120,
		startDate: '01/01/2024',
		plannedEndDate: '07/01/2027',
	},
	{
		studyId: 'CT-245',
		title: 'Gene Therapy for Hemophilia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 18,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2027',
	},
	{
		studyId: 'CT-246',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 45,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-247',
		title: 'Biologic for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 84,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2027',
	},
	{
		studyId: 'CT-248',
		title: 'Novel Approach for Anxiety Disorders',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 54,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2026',
	},
	{
		studyId: 'CT-249',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 75,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2027',
	},
	{
		studyId: 'CT-250',
		title: 'Oral Treatment for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 105,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2027',
	},
	{
		studyId: 'CT-251',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 36,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-252',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 90,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2027',
	},
	{
		studyId: 'CT-253',
		title: 'Novel Treatment for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 120,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2027',
	},
	{
		studyId: 'CT-254',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 75,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2027',
	},
	{
		studyId: 'CT-255',
		title: 'Targeted Therapy for PIK3CA-Mutated Breast Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 30,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-256',
		title: 'Novel Approach for Bipolar Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 197,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-257',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 197,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2028',
	},
	{
		studyId: 'CT-259',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 197,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-260',
		title: 'Biologic for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 197,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2028',
	},
	{
		studyId: 'CT-261',
		title: 'Novel Approach for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 197,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2027',
	},
	{
		studyId: 'CT-262',
		title: 'Targeted Therapy for HER2-Low Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 197,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2028',
	},
	{
		studyId: 'CT-263',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 197,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2028',
	},
	{
		studyId: 'CT-264',
		title: 'Innovative Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 197,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-265',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 197,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2028',
	},
	{
		studyId: 'CT-266',
		title: 'Novel Treatment for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 197,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2027',
	},
	{
		studyId: 'CT-267',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 197,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2028',
	},
	{
		studyId: 'CT-268',
		title: 'Targeted Therapy for RET-Fusion Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 197,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2025',
	},
	{
		studyId: 'CT-269',
		title: 'Novel Approach for Osteoarthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 197,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-270',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 197,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-271',
		title: 'Gene Therapy for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 197,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-272',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 197,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2025',
	},
	{
		studyId: 'CT-273',
		title: 'Biologic for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 197,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-274',
		title: 'Novel Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 197,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2025',
	},
	{
		studyId: 'CT-275',
		title: 'Targeted Therapy for BRAF-Mutated Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 197,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-276',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 197,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2026',
	},
	{
		studyId: 'CT-277',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 197,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2025',
	},
	{
		studyId: 'CT-278',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 150,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-279',
		title: 'Novel Treatment for Type 1 Diabetes',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 75,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2025',
	},
	{
		studyId: 'CT-280',
		title: 'Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 175,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-281',
		title: 'Targeted Therapy for NTRK-Fusion Cancers',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 50,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2026',
	},
	{
		studyId: 'CT-282',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 100,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2026',
	},
	{
		studyId: 'CT-283',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 200,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-284',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 25,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-285',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 60,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2026',
	},
	{
		studyId: 'CT-286',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 150,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2027',
	},
	{
		studyId: 'CT-287',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 90,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2026',
	},
	{
		studyId: 'CT-288',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 125,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-289',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 200,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-290',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 75,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2026',
	},
	{
		studyId: 'CT-291',
		title: 'Combination Therapy for Advanced Ovarian Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 140,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-292',
		title: 'Novel Treatment for Lupus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 60,
		startDate: '01/01/2024',
		plannedEndDate: '07/01/2026',
	},
	{
		studyId: 'CT-293',
		title: 'Biologic for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 175,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2027',
	},
	{
		studyId: 'CT-294',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 150,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2027',
	},
	{
		studyId: 'CT-295',
		title: 'Novel Approach for Bipolar Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 100,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-296',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 200,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2027',
	},
	{
		studyId: 'CT-297',
		title: 'Gene Therapy for Hemophilia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 30,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2027',
	},
	{
		studyId: 'CT-298',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 75,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-299',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 140,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2027',
	},
	{
		studyId: 'CT-300',
		title: 'Novel Approach for Anxiety Disorders',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 90,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2026',
	},
	{
		studyId: 'CT-301',
		title: 'Targeted Therapy for HER2-Positive Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 125,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2027',
	},
	{
		studyId: 'CT-302',
		title: 'Oral Treatment for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 175,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2027',
	},
	{
		studyId: 'CT-303',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 60,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-304',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 150,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2028',
	},
	{
		studyId: 'CT-305',
		title: 'Novel Treatment for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 200,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2028',
	},
	{
		studyId: 'CT-306',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 125,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2028',
	},
	{
		studyId: 'CT-307',
		title: 'Targeted Therapy for PIK3CA-Mutated Breast Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 80,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-308',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 144,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-309',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-310',
		title: 'Gene Therapy for Rare Metabolic Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 40,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2028',
	},
	{
		studyId: 'CT-311',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-312',
		title: 'Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2028',
	},
	{
		studyId: 'CT-313',
		title: 'Novel Approach for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '11/15/2024',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-314',
		title: 'Targeted Therapy for BRAF-Mutated Melanoma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 224,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2028',
	},
	{
		studyId: 'CT-315',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2028',
	},
	{
		studyId: 'CT-316',
		title: 'Innovative Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 160,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2025',
	},
	{
		studyId: 'CT-317',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-318',
		title: 'Novel Treatment for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2025',
	},
	{
		studyId: 'CT-319',
		title: 'Biologic for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-320',
		title: 'Targeted Therapy for RET-Fusion Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 64,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2025',
	},
	{
		studyId: 'CT-321',
		title: 'Novel Approach for Osteoarthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 200,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-322',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-323',
		title: 'Gene Therapy for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 48,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-324',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2025',
	},
	{
		studyId: 'CT-325',
		title: 'Biologic for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 224,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-326',
		title: 'Novel Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 144,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2025',
	},
	{
		studyId: 'CT-327',
		title: 'Targeted Therapy for NTRK-Fusion Cancers',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 200,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-328',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-329',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2026',
	},
	{
		studyId: 'CT-330',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2027',
	},
	{
		studyId: 'CT-331',
		title: 'Novel Treatment for Type 1 Diabetes',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2026',
	},
	{
		studyId: 'CT-332',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-333',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 80,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2026',
	},
	{
		studyId: 'CT-334',
		title: 'Novel Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 160,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2026',
	},
	{
		studyId: 'CT-335',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-336',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 40,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2027',
	},
	{
		studyId: 'CT-476',
		title: 'Targeted Therapy for RET-Fusion Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 64,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2026',
	},
	{
		studyId: 'CT-477',
		title: 'Novel Approach for Osteoarthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 200,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2027',
	},
	{
		studyId: 'CT-478',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2027',
	},
	{
		studyId: 'CT-479',
		title: 'Gene Therapy for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 48,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-480',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2026',
	},
	{
		studyId: 'CT-481',
		title: 'Biologic for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 224,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-482',
		title: 'Novel Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 144,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2026',
	},
	{
		studyId: 'CT-483',
		title: 'Targeted Therapy for NTRK-Fusion Cancers',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 200,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-484',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '01/01/2024',
		plannedEndDate: '07/01/2027',
	},
	{
		studyId: 'CT-485',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-486',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2027',
	},
	{
		studyId: 'CT-487',
		title: 'Novel Treatment for Type 1 Diabetes',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2026',
	},
	{
		studyId: 'CT-488',
		title: 'Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2027',
	},
	{
		studyId: 'CT-489',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 80,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-490',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 160,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-491',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2027',
	},
	{
		studyId: 'CT-492',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 40,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2027',
	},
	{
		studyId: 'CT-493',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-494',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2027',
	},
	{
		studyId: 'CT-495',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 144,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2026',
	},
	{
		studyId: 'CT-496',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 200,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2028',
	},
	{
		studyId: 'CT-497',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2028',
	},
	{
		studyId: 'CT-498',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2027',
	},
	{
		studyId: 'CT-499',
		title: 'Combination Therapy for Advanced Ovarian Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 224,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2028',
	},
	{
		studyId: 'CT-500',
		title: 'Novel Treatment for Lupus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2027',
	},
	{
		studyId: 'CT-501',
		title: 'Biologic for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-502',
		title: 'Targeted Therapy for HER2-Positive Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2028',
	},
	{
		studyId: 'CT-503',
		title: 'Novel Approach for Bipolar Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 160,
		startDate: '10/15/2024',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-504',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '11/01/2024',
		plannedEndDate: '05/01/2028',
	},
	{
		studyId: 'CT-506',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '12/01/2024',
		plannedEndDate: '06/01/2027',
	},
	{
		studyId: 'CT-507',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 224,
		startDate: '12/15/2024',
		plannedEndDate: '06/15/2028',
	},
	{
		studyId: 'CT-508',
		title: 'Novel Approach for Anxiety Disorders',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 144,
		startDate: '01/01/2023',
		plannedEndDate: '07/01/2025',
	},
	{
		studyId: 'CT-509',
		title: 'Targeted Therapy for BRAF-Mutated Melanoma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 200,
		startDate: '01/15/2023',
		plannedEndDate: '07/15/2026',
	},
	{
		studyId: 'CT-510',
		title: 'Oral Treatment for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '02/01/2023',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-511',
		title: 'Innovative Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '02/15/2023',
		plannedEndDate: '08/15/2025',
	},
	{
		studyId: 'CT-512',
		title: 'Combination Therapy for Metastatic Colorectal Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '03/01/2023',
		plannedEndDate: '09/01/2026',
	},
	{
		studyId: 'CT-513',
		title: 'Novel Treatment for Type 2 Diabetes',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '03/15/2023',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-514',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 200,
		startDate: '04/01/2023',
		plannedEndDate: '10/01/2026',
	},
	{
		studyId: 'CT-515',
		title: 'Targeted Therapy for PIK3CA-Mutated Breast Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 80,
		startDate: '04/15/2023',
		plannedEndDate: '10/15/2025',
	},
	{
		studyId: 'CT-516',
		title: 'Novel Approach for Fibromyalgia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 144,
		startDate: '05/01/2023',
		plannedEndDate: '11/01/2025',
	},
	{
		studyId: 'CT-517',
		title: 'Oral Treatment for Rheumatoid Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '05/15/2023',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-518',
		title: 'Gene Therapy for Rare Metabolic Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 40,
		startDate: '06/01/2023',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-519',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '06/15/2023',
		plannedEndDate: '12/15/2025',
	},
	{
		studyId: 'CT-520',
		title: 'Biologic for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '07/01/2023',
		plannedEndDate: '01/01/2027',
	},
	{
		studyId: 'CT-521',
		title: 'Novel Approach for Treatment-Resistant Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 120,
		startDate: '07/15/2023',
		plannedEndDate: '01/15/2026',
	},
	{
		studyId: 'CT-522',
		title: 'Targeted Therapy for HER2-Low Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 224,
		startDate: '08/01/2023',
		plannedEndDate: '02/01/2027',
	},
	{
		studyId: 'CT-523',
		title: 'Oral Treatment for Psoriatic Arthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 320,
		startDate: '08/15/2023',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-524',
		title: 'Innovative Approach for Migraine Prevention',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 160,
		startDate: '09/01/2023',
		plannedEndDate: '03/01/2026',
	},
	{
		studyId: 'CT-525',
		title: 'Combination Therapy for Advanced Prostate Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 280,
		startDate: '09/15/2023',
		plannedEndDate: '03/15/2027',
	},
	{
		studyId: 'CT-526',
		title: 'Novel Treatment for Systemic Lupus Erythematosus',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 96,
		startDate: '10/01/2023',
		plannedEndDate: '04/01/2026',
	},
	{
		studyId: 'CT-527',
		title: 'Biologic for Ulcerative Colitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 240,
		startDate: '10/15/2023',
		plannedEndDate: '04/15/2027',
	},
	{
		studyId: 'CT-528',
		title: 'Targeted Therapy for RET-Fusion Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 80,
		currentEnrollment: 72,
		startDate: '11/01/2023',
		plannedEndDate: '05/01/2026',
	},
	{
		studyId: 'CT-529',
		title: 'Novel Approach for Osteoarthritis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 225,
		startDate: '11/15/2023',
		plannedEndDate: '05/15/2027',
	},
	{
		studyId: 'CT-530',
		title: 'Oral Treatment for Atopic Dermatitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 315,
		startDate: '12/01/2023',
		plannedEndDate: '06/01/2027',
	},
	{
		studyId: 'CT-531',
		title: 'Gene Therapy for Duchenne Muscular Dystrophy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 60,
		currentEnrollment: 54,
		startDate: '12/15/2023',
		plannedEndDate: '06/15/2027',
	},
	{
		studyId: 'CT-532',
		title: "Innovative Treatment for Parkinson's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 135,
		startDate: '01/01/2024',
		plannedEndDate: '07/01/2026',
	},
	{
		studyId: 'CT-533',
		title: 'Biologic for Ankylosing Spondylitis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 280,
		currentEnrollment: 252,
		startDate: '01/15/2024',
		plannedEndDate: '07/15/2027',
	},
	{
		studyId: 'CT-534',
		title: 'Novel Approach for Generalized Anxiety Disorder',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 162,
		startDate: '02/01/2024',
		plannedEndDate: '08/01/2026',
	},
	{
		studyId: 'CT-535',
		title: 'Targeted Therapy for NTRK-Fusion Cancers',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 225,
		startDate: '02/15/2024',
		plannedEndDate: '08/15/2027',
	},
	{
		studyId: 'CT-536',
		title: 'Oral Treatment for Multiple Sclerosis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 360,
		startDate: '03/01/2024',
		plannedEndDate: '09/01/2027',
	},
	{
		studyId: 'CT-537',
		title: 'Innovative Approach for Epilepsy',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 108,
		startDate: '03/15/2024',
		plannedEndDate: '09/15/2026',
	},
	{
		studyId: 'CT-538',
		title: 'Combination Therapy for Metastatic Breast Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 270,
		startDate: '04/01/2024',
		plannedEndDate: '10/01/2027',
	},
	{
		studyId: 'CT-539',
		title: 'Novel Treatment for Type 1 Diabetes',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 135,
		startDate: '04/15/2024',
		plannedEndDate: '10/15/2026',
	},
	{
		studyId: 'CT-540',
		title: "Biologic for Crohn's Disease",
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 350,
		currentEnrollment: 315,
		startDate: '05/01/2024',
		plannedEndDate: '11/01/2027',
	},
	{
		studyId: 'CT-541',
		title: 'Targeted Therapy for ALK-Positive Lung Cancer',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 100,
		currentEnrollment: 90,
		startDate: '05/15/2024',
		plannedEndDate: '11/15/2026',
	},
	{
		studyId: 'CT-542',
		title: 'Novel Approach for Chronic Pain',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 200,
		currentEnrollment: 180,
		startDate: '06/01/2024',
		plannedEndDate: '12/01/2026',
	},
	{
		studyId: 'CT-543',
		title: 'Oral Treatment for Inflammatory Bowel Disease',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 360,
		startDate: '06/15/2024',
		plannedEndDate: '12/15/2027',
	},
	{
		studyId: 'CT-544',
		title: 'Gene Therapy for Beta-Thalassemia',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 50,
		currentEnrollment: 45,
		startDate: '07/01/2024',
		plannedEndDate: '01/01/2028',
	},
	{
		studyId: 'CT-545',
		title: "Innovative Treatment for Alzheimer's Disease",
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 120,
		currentEnrollment: 108,
		startDate: '07/15/2024',
		plannedEndDate: '01/15/2027',
	},
	{
		studyId: 'CT-546',
		title: 'Biologic for Severe Asthma',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 300,
		currentEnrollment: 270,
		startDate: '08/01/2024',
		plannedEndDate: '02/01/2028',
	},
	{
		studyId: 'CT-547',
		title: 'Novel Approach for Major Depression',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 180,
		currentEnrollment: 162,
		startDate: '08/15/2024',
		plannedEndDate: '02/15/2027',
	},
	{
		studyId: 'CT-548',
		title: 'Targeted Therapy for EGFR-Mutated Lung Cancer',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 250,
		currentEnrollment: 225,
		startDate: '09/01/2024',
		plannedEndDate: '03/01/2028',
	},
	{
		studyId: 'CT-549',
		title: 'Oral Treatment for Psoriasis',
		phase: 'Phase 3',
		status: 'Recruiting',
		enrollmentTarget: 400,
		currentEnrollment: 360,
		startDate: '09/15/2024',
		plannedEndDate: '03/15/2028',
	},
	{
		studyId: 'CT-550',
		title: 'Innovative Approach for Multiple Sclerosis',
		phase: 'Phase 2',
		status: 'Recruiting',
		enrollmentTarget: 150,
		currentEnrollment: 135,
		startDate: '10/01/2024',
		plannedEndDate: '04/01/2027',
	},
];

export default DATA;
